Urine amino and organic acids analysis in developmental delay or intellectual disability.
OBJECTIVE
To determine the proportion of urine amino and organic acids screening tests (UMS) undertaken for patients referred with developmental delay or intellectual disability (DD/ID), and within the group with DD/ID, to determine the diagnostic yield, the proportion of diagnoses with a therapy and the associated recurrence risks.


METHODS
A retrospective review of request forms and results of UMS, in individuals older than 28 days, referred to the Women's and Children's Hospital, North Adelaide, between 1 January 1992 and 31 December 1998 was carried out. Urine was analysed by ion exchange chromatography (amino acids), gas chromatography/mass spectrometry (organic acids), colorimetric assay (orotic acid) and stable isotope-dilution mass spectrometry (trimethylamine).


RESULTS
A total of 3316 samples were received, 1447 being from patients with DD/ID. A diagnosis was determined for 1.8% of all referrals. For patients with DD/ID, the diagnostic yield was 1.1%, with a similar yield for isolated DD/ID and DD/ID with other features (9/828 vs 7/619; chi2 = 0.006; P = 0.93). Specific therapies were available for 69% of diagnoses associated with DD/ID and 87.5% had known Mendelian or mitochondrial inheritance.


CONCLUSIONS
Urine metabolic screening is an important part of the evaluation of children with DD/ID as it can enable families to make reproductive decisions and children to receive appropriate therapy early.
D000596:Amino Acids / Q000652:urine*; D002648:Child; D002675:Child, Preschool; D002852:Chromatography, Ion Exchange; D002658:Developmental Disabilities / Q000175:diagnosis / Q000628:therapy / Q000652:urine*; D005260:Female; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D007223:Infant; D008607:Intellectual Disability / Q000175:diagnosis / Q000652:urine*; D008297:Male; D009963:Orotic Acid / Q000652:urine*; D012189:Retrospective Studies
D000596:Amino Acids; D009963:Orotic Acid